TY - JOUR
T1 - Chemical Ablation of Ventricular Tachycardia Using Coronary Arterial and Venous Systems
AU - Flautt, Thomas
AU - Valderrábano, Miguel
N1 - Funding Information:
This study was supported by the Charles Burnett III and Lois and Carl Davis Centennial Chair endowments (Houston, Texas, USA).
Copyright © 2022 Elsevier Inc. All rights reserved.
PY - 2022/12
Y1 - 2022/12
N2 - Radiofrequency catheter ablation (RFCA) is the first-line therapy for treatment of drug refractory ventricular arrhythmias (VAs), however, creating a safe, transmural lesion can be difficult. Ethanol in the arterial system has been used as an adjunctive therapy to RFCA since 1986, but with limited use due to technical and efficacy limitations. Venous ethanol is emerging as powerful alternative.
AB - Radiofrequency catheter ablation (RFCA) is the first-line therapy for treatment of drug refractory ventricular arrhythmias (VAs), however, creating a safe, transmural lesion can be difficult. Ethanol in the arterial system has been used as an adjunctive therapy to RFCA since 1986, but with limited use due to technical and efficacy limitations. Venous ethanol is emerging as powerful alternative.
KW - Ethanol
KW - Radiofrequency catheter ablation
KW - Transcoronary ethanol ablation
KW - Ventricular arrhythmia
KW - Ventricular tachycardia
KW - VT ablation
KW - Tachycardia, Ventricular
KW - Coronary Vessels/surgery
KW - Humans
KW - Ethanol/therapeutic use
KW - Treatment Outcome
KW - Catheter Ablation
UR - http://www.scopus.com/inward/record.url?scp=85141974821&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85141974821&partnerID=8YFLogxK
U2 - 10.1016/j.ccep.2022.08.002
DO - 10.1016/j.ccep.2022.08.002
M3 - Review article
C2 - 36396190
AN - SCOPUS:85141974821
SN - 1877-9182
VL - 14
SP - 743
EP - 756
JO - Cardiac Electrophysiology Clinics
JF - Cardiac Electrophysiology Clinics
IS - 4
ER -